← Open Payments lookup

MARY HUNT: Open Payments

NPI 1457816688 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$428 in 19 payments from 11 companies in 2025. Trend: 2023 $505 · 2024 $117 · 2025 $428

Food & beverage: $428
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$85
ABBVIE INC.2$56
Madrigal Pharmaceuticals3$48
Takeda Pharmaceuticals U.S.A., Inc.2$47
Baxter Healthcare1$32
Alexion Pharmaceuticals, Inc.2$32
La Jolla Pharmaceutical Company1$29
Eisai Inc.1$27
Pacira Pharmaceuticals Incorporated1$26
Merck Sharp & Dohme LLC1$24

Products named: XIFAXAN, REZDIFFRA, LIVTENCITY, PERCLOT, ULTOMIRIS, GIAPREZA, Lenvima, Exparel.

Industry payments across TX — which companies pay providers there.